FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Leo Paljärvi

Research Profile

Disorders

Anatomy

Procedures

Immunohistochemistry

Chemicals & Drugs

Living Beings

Rats

Concepts & Ideas

Neuropsychological Tests

Co-author Network

Publications

TOP 3
Soili Paljärvi; Sari Rissanen; Sirkka Sinkkonen; Leo Paljärvi
What happens to quality in integrated homecare? A 15-year follow-up study.
Sally Järvelä; Kristiina Nordfors; Miia Jansson; Joonas A Haapasalo; Pauli Helén; Leo Paljärvi; Hannu Kalimo; Vuokko Kinnula; Ylermi Soini; Hannu Haapasalo
Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas.
K Nordfors; Joonas A Haapasalo; Pauli Helén; A Paetau; Leo Paljärvi; Hannu Kalimo; Vuokko L Kinnula; Ylermi Soini; Hannu Haapasalo
Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Leo Paljärvi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Soili Paljärvi; Sari Rissanen; Sirkka Sinkkonen; Leo Paljärvi
What happens to quality in integrated homecare? A 15-year follow-up study.
International journal of integrated care 2011;11():e021.
2008: Sally Järvelä; Kristiina Nordfors; Miia Jansson; Joonas A Haapasalo; Pauli Helén; Leo Paljärvi; Hannu Kalimo; Vuokko Kinnula; Ylermi Soini; Hannu Haapasalo
Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas.
Journal of neuro-oncology 2008;90(3):283-91.
2007: K Nordfors; Joonas A Haapasalo; Pauli Helén; A Paetau; Leo Paljärvi; Hannu Kalimo; Vuokko L Kinnula; Ylermi Soini; Hannu Haapasalo
Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas.
Clinical neuropathology 2007;26(5):210-8.
2007: Susanna Narkilahti; Leena Jutila; Irina Alafuzoff; Kari Karkola; Leo Paljärvi; Arto Immonen; Matti Vapalahti; Esa Mervaala; Reetta Kälviäinen; Asla Pitkänen
Increased expression of caspase 2 in experimental and human temporal lobe epilepsy.
Neuromolecular medicine 2007;9(2):129-44.
2006: Sally Järvelä; Järvelä Sally; Helena Bragge; Bragge Helena; Niina Paunu; Paunu Niina; Timo Järvelä; Järvelä Timo; Leo Paljärvi; Paljärvi Leo; Hannu Kalimo; Kalimo Hannu; Pauli Helén; Helén Pauli; Vuokko Kinnula; Kinnula Vuokko; Ylermi Soini; Soini Ylermi; Hannu Haapasalo; Haapasalo Hannu
Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival.
Journal of neuro-oncology 2006;77(2):131-40.
2005: Tuula Pirttilä; Anni Manninen; Leena Jutila; Jari Nissinen; Reetta Kälviäinen; Matti Vapalahti; Arto Immonen; Leo Paljärvi; Kari Karkola; Irina Alafuzoff; Esa Mervaala; Asla Pitkänen
Cystatin C expression is associated with granule cell dispersion in epilepsy.
Annals of neurology 2005;58(2):211-23.
2004: Arto Immonen; Leena Jutila; R Kälviäinen; Esa Mervaala; Kaarina Partanen; Juhani Partanen; Ritva Vanninen; Aarne Ylinen; Irina Alafuzoff; Leo Paljärvi; Heleena Hurskainen; Jaakko Rinne; Matti Puranen; Matti Vapalahti
Preoperative clinical evaluation, outline of surgical technique and outcome in temporal lobe epilepsy.
Advances and technical standards in neurosurgery 2004;29():87-132.
2002: S Savolainen; Heleena Hurskainen; Leo Paljärvi; Irina Alafuzoff; Matti Vapalahti
Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test.
Acta neurochirurgica 2002;144(6):515-23; discussion 523.
2002: Leena Jutila; Arto Immonen; Kaarina Partanen; Juhani Partanen; Esa Mervaala; Aarne Ylinen; Irina Alafuzoff; Leo Paljärvi; Kari Karkola; Matti Vapalahti; Asla Pitkänen
Neurobiology of epileptogenesis in the temporal lobe.
Advances and technical standards in neurosurgery 2002;27():5-22.
2001: H E Miettinen; Niina Paunu; Immo Rantala; Hannu Kalimo; Leo Paljärvi; Heikki Helin; Hannu Haapasalo
Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique.
Journal of neuro-oncology 2001;55(1):29-37.
2001: S Savolainen; Jari Karhu; Ari Pääkkönen; Leo Paljärvi; Juhani Partanen; Irina Alafuzoff; Matti Vapalahti
Auditory event-related potentials differentiate patients with normal pressure hydrocephalus and patients with concomitant Alzheimer's disease verified by brain biopsy.
Neuroreport 2001;12(1):33-7.
2000: H E Miettinen; Tero A H Järvinen; U Kellner; Päivikki Kauraniemi; R Parwaresch; Immo Rantala; Hannu Kalimo; Leo Paljärvi; Jorma Isola; Hannu Haapasalo
High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas.
Neuropathology and applied neurobiology 2000;26(6):504-12.
2000: Anu-Maaria Sandmair; Sami Loimas; P Puranen; Arto Immonen; Maija Kossila; Matti Puranen; Heleena Hurskainen; Kristiina Tyynelä; Mikko P Turunen; Ritva Vanninen; Pauliina Lehtolainen; Leo Paljärvi; Risto Johansson; Matti Vapalahti; Seppo Ylä-Herttuala
Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
Human gene therapy 2000;11(16):2197-205.
2000: S Savolainen; Mikko P Laakso; Leo Paljärvi; Irina Alafuzoff; Heleena Hurskainen; Kaarina Partanen; Hilkka Soininen; Matti Vapalahti
MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysis.
AJNR. American journal of neuroradiology 2000;21(2):409-14.
2000: Asla Pitkänen; Jari Nissinen; Katarzyna Lukasiuk; Leena Jutila; Leo Paljärvi; Tuuli Salmenperä; Kari Karkola; Matti Vapalahti; Aarne Ylinen
Association between the density of mossy fiber sprouting and seizure frequency in experimental and human temporal lobe epilepsy.
Epilepsia 2000;41 Suppl 6():S24-9.
1999: Hannu Haapasalo; Satu-Leena Sallinen; Pauli Sallinen; Pauli Helén; Juha Jääskeläinen; T T Salmi; A Paetau; Leo Paljärvi; T Visakorpi; Hannu Kalimo
Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas.
Neuropathology and applied neurobiology 1999;25(2):134-42.
1999: Helena Miettinen; Juha Kononen; Pauli Sallinen; Hannu Alho; P Helen; Heikki Helin; Hannu Kalimo; Leo Paljärvi; Jorma Isola; Hannu Haapasalo
CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
Journal of neuro-oncology 1999;41(3):205-11.
1999: S Savolainen; Leo Paljärvi; Matti Vapalahti
Prevalence of Alzheimer's disease in patients investigated for presumed normal pressure hydrocephalus: a clinical and neuropathological study.
Acta neurochirurgica 1999;141(8):849-53.
1998: Mia Mikkonen; Hilkka Soininen; R Kälviänen; Tero Tapiola; Aarne Ylinen; Matti Vapalahti; Leo Paljärvi; Asla Pitkänen
Remodeling of neuronal circuitries in human temporal lobe epilepsy: increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex.
Annals of neurology 1998;44(6):923-34.
1998: Juhana M Hakumäki; harish poptani; AM Puumalainen; Sami Loimas; Leo Paljärvi; Seppo Ylä-Herttuala; Risto A Kauppinen
Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response.
Cancer research 1998;58(17):3791-9.
1998: AM Puumalainen; Matti Vapalahti; RS Agrawal; Maija Kossila; Jari A Laukkanen; Pauliina Lehtolainen; Helena Viita; Leo Paljärvi; Ritva Vanninen; Seppo Ylä-Herttuala
Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses.
Human gene therapy 1998;9(12):1769-74.
1998: H Sorvari; Riitta Miettinen; Hilkka Soininen; Leo Paljärvi; Kari Karkola; Asla Pitkänen
Calretinin-immunoreactive terminals make synapses on calbindin D28k-immunoreactive neurons in the lateral nucleus of the human amygdala.
Brain research 1998;783(2):355-8.
1996: Tuula Pirttilä; Hilkka Soininen; Outi Kopra; T Lehtimäki; Nenad Bogdanovic; Leo Paljärvi; O Kosunen; Bengt Winblad; PJ Riekkinen; Henryk M Wisniewski; Pankaj D Mehta
Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls.
Brain research 1996;722(1-2):71-7.
1996: Tuula Pirttilä; Pankaj D Mehta; Hilkka Soininen; K S Kim; Outi Kopra; Leo Paljärvi; O Kosunen; PJ Riekkinen; Henryk M Wisniewski
Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain.
Archives of neurology 1996;53(2):189-93.
1996: O Kosunen; Hilkka Soininen; Leo Paljärvi; Outi Kopra; S Talasniemi; PJ Riekkinen
Diagnostic accuracy of Alzheimer's disease: a neuropathological study.
Acta neuropathologica 1996;91(2):185-93.
1995: H Sorvari; Hilkka Soininen; Leo Paljärvi; Kari Karkola; Asla Pitkänen
Distribution of parvalbumin-immunoreactive cells and fibers in the human amygdaloid complex.
The Journal of comparative neurology 1995;360(2):185-212.
1995: Outi Kopra; Maarit Lehtovirta; Hilkka Soininen; Seppo Helisalmi; Arto Mannermaa; H Sorvari; O Kosunen; Leo Paljärvi; Markku Ryynänen; PJ Riekkinen
Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.
Neurobiology of aging 1995;16(4):505-13.
1995: O Kosunen; S Talasniemi; Maarit Lehtovirta; Outi Kopra; Seppo Helisalmi; Arto Mannermaa; Leo Paljärvi; Markku Ryynänen; PJ Riekkinen; Hilkka Soininen
Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.
Stroke; a journal of cerebral circulation 1995;26(5):743-8.
1995: Hilkka Soininen; O Kosunen; Seppo Helisalmi; Arto Mannermaa; Leo Paljärvi; S Talasniemi; Markku Ryynänen; PJ Riekkinen
A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele.
Neuroscience letters 1995;187(2):79-82.
1995: Outi Kopra; Hilkka Soininen; H Sorvari; O Kosunen; Leo Paljärvi; Esa H Koivisto; PJ Riekkinen
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease.
Neuroscience 1995;64(2):375-84.
1994: Outi Kopra; Hilkka Soininen; Stina Syrjänen; H Neittaanmäki; Leo Paljärvi; O Kosunen; Kari Syrjänen; PJ Riekkinen
beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study.
Archives of neurology 1994;51(8):799-804.
1993: Maija-Riitta Hirvonen; Leo Paljärvi; Kai Savolainen
Sustained effects of pilocarpine-induced convulsions on brain inositol and inositol monophosphate levels and brain morphology in young and old male rats.
Toxicology and applied pharmacology 1993;122(2):290-9.
1993: Maija-Riitta Hirvonen; Leo Paljärvi; Kai Savolainen
Malaoxon-induced neurotoxicity in old rats: alterations in cerebral inositol lipid signalling, brain tissue calcium levels and early neuronal injury.
Toxicology 1993;79(2):157-67.
1993: Hilkka Soininen; K J Reinikainen; Matti Puranen; Eeva-Liisa Helkala; Leo Paljärvi; PJ Riekkinen
Wide third ventricle correlates with low choline acetyltransferase activity of the neocortex in Alzheimer patients.
Alzheimer disease and associated disorders 1993;7(1):39-47.
1992: Hilkka Soininen; K J Reinikainen; Juhani Partanen; Eeva-Liisa Helkala; Leo Paljärvi; PJ Riekkinen
Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease.
Neuroscience 1992;49(3):529-35.
1992: Hilkka Soininen; K Reinikainen; Juhani Partanen; E Mervaala; Leo Paljärvi; Eeva-Liisa Helkala; PJ Riekkinen
Slowing of the dominant occipital rhythm in electroencephalogram is associated with low concentration of noradrenaline in the thalamus in patients with Alzheimer's disease.
Neuroscience letters 1992;137(1):5-8.
1992: Hilkka Soininen; Stina Syrjänen; Outi Kopra; H Neittaanmäki; Riitta Miettinen; Leo Paljärvi; Kari Syrjänen; Konrad Beyreuther; PJ Riekkinen
Amyloid beta-protein deposition in skin of patients with dementia.
Lancet 1992;339(8787):245.
1991: Stina Syrjänen; O Heinonen; Riitta Miettinen; Leo Paljärvi; Kari Syrjänen; PJ Riekkinen
Short biotinylated oligonucleotides bind non-specifically to senile plaques of Alzheimer's disease.
Neuroscience letters 1991;130(1):89-91.
1990: Maija-Riitta Hirvonen; Leo Paljärvi; A Naukkarinen; Hannu Komulainen; Kai Savolainen
Potentiation of malaoxon-induced convulsions by lithium: early neuronal injury, phosphoinositide signaling, and calcium.
Toxicology and applied pharmacology 1990;104(2):276-89.
1989: Jouni Sirviö; J O Rinne; Antti Valjakka; UK Rinne; PJ Riekkinen; Leo Paljärvi
Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson's disease.
Journal of the neurological sciences 1989;90(1):23-32.
1989: Maija-Riitta Hirvonen; Hannu Komulainen; Leo Paljärvi; Kai Savolainen
Time-course of malaoxon-induced alterations in brain regional inositol-1-phosphate levels in convulsing and nonconvulsing rats.
Neurochemical research 1989;14(2):143-7.
1988: K J Reinikainen; Leo Paljärvi; Toivo Halonen; O Malminen; V M Kosma; M Laakso; PJ Riekkinen
Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.
Neurobiology of aging 1988;9(3):245-52.
1988: K J Reinikainen; Leo Paljärvi; M Huuskonen; Hilkka Soininen; Markku Laakso; PJ Riekkinen
A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.
Journal of the neurological sciences 1988;84(1):101-16.
1988: K J Reinikainen; PJ Riekkinen; Leo Paljärvi; Hilkka Soininen; Eeva-Liisa Helkala; Jukka Jolkkonen; Markku Laakso
Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.
Neurochemical research 1988;13(2):135-46.
1987: PJ Riekkinen; Hilkka Soininen; Jouni Sirviö; K Reinikainen; Eeva-Liisa Helkala; Leo Paljärvi
Dementia without cholinergic deficit.
Gerontology 1987;33(3-4):268-72.